AtriCure, Inc.

NASDAQ:ATRC

27.99 (USD) • At close September 18, 2024
Bedrijfsnaam AtriCure, Inc.
Symbool ATRC
Munteenheid USD
Prijs 27.99
Beurswaarde 1,363,043,025
Dividendpercentage 0%
52-weken bereik 18.94 - 44.64
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Michael H. Carrel
Website https://www.atricure.com

An error occurred while fetching data.

Over AtriCure, Inc.

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as

Vergelijkbare Aandelen

Twist Bioscience Corporation logo

Twist Bioscience Corporation

TWST

47.02 USD

InMode Ltd. logo

InMode Ltd.

INMD

17.46 USD

Alignment Healthcare, Inc. logo

Alignment Healthcare, Inc.

ALHC

11.38 USD

Allscripts Healthcare Solutions, Inc. logo

Allscripts Healthcare Solutions, Inc.

MDRX

9.25 USD

Sage Therapeutics, Inc. logo

Sage Therapeutics, Inc.

SAGE

7.59 USD

Amicus Therapeutics, Inc. logo

Amicus Therapeutics, Inc.

FOLD

10.91 USD

Canopy Growth Corporation logo

Canopy Growth Corporation

CGC

4.77 USD

Fate Therapeutics, Inc. logo

Fate Therapeutics, Inc.

FATE

3.88 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)